Abstract
Due to long corticosteroid therapy in patients with COVID-19, in case of cough, dyspnea, and weight loss, emerging pulmonary aspergillosis and lophomoniasis should be ruled out.
Author supplied keywords
Cite
CITATION STYLE
APA
Sharifpour, A., Zakariaei, Z., Fakhar, M., Banimostafavi, E. S., Nakhaei, M., & Soleymani, M. (2021). Post-COVID-19 co-morbidity of emerged Lophomonas infection and invasive pulmonary aspergillosis: First case report. Clinical Case Reports, 9(9). https://doi.org/10.1002/ccr3.4822
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free